van Ommen-Nijhof, A., Jacobse, J. N., Steggink, L. C., Lefrandt, J. D., Gietema, J. A., van Leeuwen, F. E., . . . Sonke, G. S. (2022). Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors. Breast Cancer Research and Treatment, 196(3), 591-602. https://doi.org/10.1007/s10549-022-06714-0
Chicago-referens (17:e uppl.)van Ommen-Nijhof, Annemiek, Judy N. Jacobse, Lars C. Steggink, Joop D. Lefrandt, Jourik A. Gietema, Flora E. van Leeuwen, Michael Schaapveld, och Gabe S. Sonke. "Adjuvant Aromatase Inhibitor Therapy and Early Markers for Cardiovascular Disease in Breast Cancer Survivors." Breast Cancer Research and Treatment 196, no. 3 (2022): 591-602. https://doi.org/10.1007/s10549-022-06714-0.
MLA-referens (9:e uppl.)van Ommen-Nijhof, Annemiek, et al. "Adjuvant Aromatase Inhibitor Therapy and Early Markers for Cardiovascular Disease in Breast Cancer Survivors." Breast Cancer Research and Treatment, vol. 196, no. 3, 2022, pp. 591-602, https://doi.org/10.1007/s10549-022-06714-0.
